Protheragen-ING
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide, a potent kinase inhibitor, is prescribed for the management of diverse malignancies such as lung carcinoma and melanoma. Its mechanism of action encompasses the suppression of pivotal pathways implicated in the proliferation and advancement of neoplastic tissues.
More Information
Supplier Page
Protheragen-ING
2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide, is a precursor in the synthesis of Dasatinib, a protein tyrosine kinase inhibitor, and also for 2-Amino-thiazole-5-carboxylic Acid Phenylamide Derivatives, used as potent and selective anti-tumor drugs.
More Information
Supplier Page
Protheragen-ING
2-Aminoethylmethylsulfone hydrochloride is a compound extensively utilized within the biomedical realm due to its acclaimed therapeutic potential across a multifaceted spectrum of ailments, specifically targeting rheumatoid arthritis and osteoarthritis. Its profound anti-inflammatory and analgesic attributes render it a prime contender for combatting afflictions characterized by pain and inflammation.
More Information
Supplier Page
Protheragen-ING
2-Formylfuran-5-boronic acid is a reagent used in Suzuki cross-couplings with deactivated aryl bromides and activated aryl chlorides.
More Information
Supplier Page
Protheragen-ING